| Ketotifen | |||
| See details |
$0.95
(€0.75)
|
||
The Actavis Group is one of the worlds leading players in the development, manufacture and sale of high-quality generic pharmaceuticals. The successful integration of a number of acquisitions has helped position Actavis among the worlds largest companies in the industry.
| Ketotifen | |||
| See details |
$0.95
(€0.75)
|
||